EYPT
Price
$15.08
Change
-$0.76 (-4.80%)
Updated
Jan 16 closing price
Capitalization
1.25B
46 days until earnings call
Intraday BUY SELL Signals
LYRA
Price
$1.99
Change
+$0.04 (+2.05%)
Updated
Jan 16 closing price
Capitalization
3.53M
Intraday BUY SELL Signals
Interact to see
Advertisement

EYPT vs LYRA

Header iconEYPT vs LYRA Comparison
Open Charts EYPT vs LYRABanner chart's image
EyePoint
Price$15.08
Change-$0.76 (-4.80%)
Volume$882.55K
Capitalization1.25B
Lyra Therapeutics
Price$1.99
Change+$0.04 (+2.05%)
Volume$42.62K
Capitalization3.53M
EYPT vs LYRA Comparison Chart in %
EYPT
Daily Signal:
Gain/Loss:
LYRA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EYPT vs. LYRA commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and LYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (EYPT: $15.08 vs. LYRA: $1.99)
Brand notoriety: EYPT and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 77% vs. LYRA: 46%
Market capitalization -- EYPT: $1.25B vs. LYRA: $3.53M
EYPT [@Biotechnology] is valued at $1.25B. LYRA’s [@Biotechnology] market capitalization is $3.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileLYRA’s FA Score has 1 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • LYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 5 TA indicator(s) are bullish while LYRA’s TA Score has 4 bullish TA indicator(s).

  • EYPT’s TA Score: 5 bullish, 4 bearish.
  • LYRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than LYRA.

Price Growth

EYPT (@Biotechnology) experienced а -7.09% price change this week, while LYRA (@Biotechnology) price change was -47.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

EYPT is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($1.25B) has a higher market cap than LYRA($3.53M). EYPT YTD gains are higher at: -17.460 vs. LYRA (-35.390). LYRA has higher annual earnings (EBITDA): -31.9M vs. EYPT (-201.16M). EYPT has more cash in the bank: 204M vs. LYRA (22.1M). EYPT has less debt than LYRA: EYPT (21.3M) vs LYRA (31.4M). EYPT has higher revenues than LYRA: EYPT (42.3M) vs LYRA (600K).
EYPTLYRAEYPT / LYRA
Capitalization1.25B3.53M35,334%
EBITDA-201.16M-31.9M631%
Gain YTD-17.460-35.39049%
P/E RatioN/AN/A-
Revenue42.3M600K7,050%
Total Cash204M22.1M923%
Total Debt21.3M31.4M68%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTLYRA
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 28 days ago
86%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signal:
Gain/Loss:
LYRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBPYX39.500.02
+0.05%
ClearBridge Small Cap Growth I
ECRAX15.73N/A
N/A
Eaton Vance All Asset Strategy C
LZCOX10.83-0.01
-0.09%
Lazard US Small Cap Equity Select Open
FNGRX17.58-0.02
-0.11%
Franklin Intl Growth R
NPRTX53.83-0.13
-0.24%
Neuberger Large Cap Value Inv

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-4.80%
LYRA - EYPT
58%
Loosely correlated
+2.31%
ATHE - EYPT
54%
Loosely correlated
+4.23%
OCUL - EYPT
49%
Loosely correlated
-0.09%
IDYA - EYPT
46%
Loosely correlated
-0.61%
AVBP - EYPT
46%
Loosely correlated
-4.75%
More

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if LYRA jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+2.31%
EYPT - LYRA
58%
Loosely correlated
-4.80%
VERA - LYRA
52%
Loosely correlated
+0.50%
KYMR - LYRA
42%
Loosely correlated
-2.22%
CLNN - LYRA
39%
Loosely correlated
-1.17%
ERAS - LYRA
34%
Loosely correlated
+0.63%
More